<p>Riverbend Wealth Management LLC 在最近向证券交易委员会提交的文件中表示，在第四季度购买了 Medtronic plc (NYSE:MDT - 免费报告) 的新头寸。该公司购买了 2,955 股医疗技术公司的股票，价值约为 237,000 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
<p>其他几家机构投资者和对冲基金也对 MDT 的头寸进行了调整。Copley Financial Group Inc. 在第三季度购买了价值约 694,000 美元的 Medtronic 新股份。Franklin Street Advisors Inc. NC 在第四季度将其在 Medtronic 的持股增加了 32.6%。Franklin Street Advisors Inc. NC 目前拥有 73,517 股医疗技术公司的股票，价值 5,873,000 美元，在此期间又购买了 18,057 股。Y Intercept Hong Kong Ltd 在第三季度将其在 Medtronic 的股份增加了 322.6%。Y Intercept Hong Kong Ltd 目前拥有 73,593 股医疗技术公司的股票，价值 6,626,000 美元，在上个季度又购买了 56,178 股。Olstein Capital Management L.P. 在第四季度将其在 Medtronic 的持股增加了 8.0%。Olstein Capital Management L.P. 目前拥有 94,000 股医疗技术公司的股票，价值 7,509,000 美元，在此期间又购买了 7,000 股。最后，捷克国家银行在第四季度将其在 Medtronic 的头寸提高了 6.4%。捷克国家银行目前拥有 278,065 股医疗技术公司的股票，价值 22,212,000 美元，在上个季度又购买了 16,786 股。当前 82.06% 的股票由机构投资者持有。</p>
<h2>Medtronic 价格表现</h2>
<p>NYSE MDT 的股票周二开盘价为 93.75 美元。Medtronic plc 的 52 周低点为 75.96 美元，52 周高点为 96.25 美元。该公司的市值为 1202.4 亿美元，市盈率为 28.50，市盈增长比率为 2.22，贝塔值为 0.80。该公司的债务与股本比率为 0.48，速动比率为 1.39，流动比率为 1.90。该业务的 50 天简单移动平均线为 88.62 美元，200 天简单移动平均线为 87.84 美元。</p>
<ul>
<li>Medtronic 的扩张势头增强——市场转变的时机到了吗？</li>
</ul>
<p>Medtronic (NYSE:MDT - 获取免费报告) 最近于 2 月 18 日星期二发布了其财报。该医疗技术公司报告本季度每股收益为 1.39 美元，超出市场共识预期的 1.36 美元，超出幅度为 0.03 美元。该公司本季度的收入为 82.9 亿美元，而市场共识预期为 83.3 亿美元。Medtronic 的净利润率为 12.83%，股本回报率为 14.07%。整体来看，股票分析师预计 Medtronic plc 本财年的每股收益将达到 5.46。</p>
<h2>Medtronic 股息公告</h2>
<p>该公司最近宣布了季度股息，将于 4 月 11 日星期五支付。3 月 28 日星期五的股东将获得每股 0.70 美元的股息。除息日期为 3 月 28 日星期五。这代表着年化股息为 2.80 美元，收益率为 2.99%。Medtronic 的股息支付比率目前为 85.11%。</p>
<h2>Medtronic 的内部买卖</h2>
<ul>
<li>Intuitive Surgical 在机器人手术创新中领先</li>
</ul>
<p>在相关消息中，执行副总裁 Brett A. Wall 于 1 月 24 日星期五出售了 12,437 股 Medtronic 股票。该股票以平均价格 90.00 美元出售，总交易额为 1,119,330.00 美元。出售完成后，该执行副总裁现在拥有 40,979 股公司股票，价值 3,688,110 美元。此次交易使其持股减少了 23.28%。该交易已在向 SEC 提交的文件中披露，文件可通过此超链接获取。公司内部人士持有公司股票的 0.20%。</p>
<h2>分析师的升级和降级</h2>
<p>一些股票分析师最近对该公司发布了报告。富国银行将 Medtronic 的目标价从 106.00 美元下调至 98.00 美元，并在 11 月 20 日的研究报告中对该股票给予了 “增持” 评级。花旗集团将 Medtronic 的评级从 “中性” 上调至 “买入”，并在 3 月 4 日的研究报告中将其目标价从 92.00 美元上调至 107.00 美元。加拿大皇家银行在 2 月 19 日的研究报告中重申了 “跑赢大盘” 评级，并对 Medtronic 的股票设定了 105.00 美元的目标价。Truist Financial 在 12 月 18 日的报告中将 Medtronic 的目标价从 93.00 美元下调至 89.00 美元，并对该股票给予了 “持有” 评级。最后，Robert W. Baird 在 2 月 19 日的报告中将 Medtronic 的目标价从 90.00 美元上调至 91.00 美元，并对该股票给予了 “中性” 评级。一位研究分析师对该股票给予了卖出评级，八位给予了持有评级，六位给予了买入评级，一位给予了强烈买入评级。根据 MarketBeat.com 的数据，Medtronic 的共识评级为 “持有”，共识目标价为 96.07 美元。</p>
<p><strong>查看我们最新的 Medtronic 股票报告</strong></p>
<h2>Medtronic 公司简介</h2>
<p>(免费报告)</p>
<p>Medtronic plc 开发、制造并销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
<h2>特色文章</h2>
<ul>
<li>我们更看好的五只股票超过美敦力</li>
<li>多伦多证券交易所创业板（前身为加拿大创业交易所）</li>
<li>如何在通货膨胀上升时保护你的投资组合</li>
<li>什么是支撑位？</li>
<li>3 只在 2025 年逆势而上并蓬勃发展的科技股</li>
<li>股息贵族名单中的最佳：通过贵族指数积累财富</li>
<li>尽管面临挑战，诺和诺德计划击败 GLP-1 竞争对手</li>
</ul>
<p><strong>想知道其他对美敦力感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com 获取美敦力 plc（NYSE:MDT - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在美敦力吗？</h2>
<p>在考虑美敦力之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
<p>虽然美敦力目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

美敦力

<p>Riverbend Wealth Management LLC 在第四季度收购了美敦力（Medtronic plc，NYSE:MDT）的新股份，购买了 2,955 股，价值约为 237,000 美元。其他机构投资者也调整了他们在 MDT 的持仓。美敦力报告了第四季度每股收益为 1.39 美元，超出预期，收入为 82.9 亿美元。公司宣布每股季度股息为 0.70 美元，将于 4 月 11 日支付。分析师对美敦力的评级各不相同，目标价格范围从 89 美元到 107 美元</p>

<p>Riverbend Wealth Management LLC bought a new position in Medtronic plc (NYSE:MDT - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The firm bought 2,955 shares of the medical technology company's stock, valued at approximately $237,000.</p>
<div class="lb-trans"><p>Riverbend Wealth Management LLC 在最近向证券交易委员会提交的文件中表示，在第四季度购买了 Medtronic plc (NYSE:MDT - 免费报告) 的新头寸。该公司购买了 2,955 股医疗技术公司的股票，价值约为 237,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 02/17 - 02/21</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also made changes to their positions in MDT. Copley Financial Group Inc. purchased a new stake in Medtronic in the 3rd quarter valued at about $694,000. Franklin Street Advisors Inc. NC boosted its holdings in shares of Medtronic by 32.6% in the fourth quarter. Franklin Street Advisors Inc. NC now owns 73,517 shares of the medical technology company's stock valued at $5,873,000 after purchasing an additional 18,057 shares during the period. Y Intercept Hong Kong Ltd grew its stake in Medtronic by 322.6% in the third quarter. Y Intercept Hong Kong Ltd now owns 73,593 shares of the medical technology company's stock worth $6,626,000 after purchasing an additional 56,178 shares in the last quarter. Olstein Capital Management L.P. increased its holdings in Medtronic by 8.0% during the 4th quarter. Olstein Capital Management L.P. now owns 94,000 shares of the medical technology company's stock worth $7,509,000 after purchasing an additional 7,000 shares during the period. Finally, Czech National Bank raised its position in Medtronic by 6.4% during the 4th quarter. Czech National Bank now owns 278,065 shares of the medical technology company's stock valued at $22,212,000 after purchasing an additional 16,786 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他几家机构投资者和对冲基金也对 MDT 的头寸进行了调整。Copley Financial Group Inc. 在第三季度购买了价值约 694,000 美元的 Medtronic 新股份。Franklin Street Advisors Inc. NC 在第四季度将其在 Medtronic 的持股增加了 32.6%。Franklin Street Advisors Inc. NC 目前拥有 73,517 股医疗技术公司的股票，价值 5,873,000 美元，在此期间又购买了 18,057 股。Y Intercept Hong Kong Ltd 在第三季度将其在 Medtronic 的股份增加了 322.6%。Y Intercept Hong Kong Ltd 目前拥有 73,593 股医疗技术公司的股票，价值 6,626,000 美元，在上个季度又购买了 56,178 股。Olstein Capital Management L.P. 在第四季度将其在 Medtronic 的持股增加了 8.0%。Olstein Capital Management L.P. 目前拥有 94,000 股医疗技术公司的股票，价值 7,509,000 美元，在此期间又购买了 7,000 股。最后，捷克国家银行在第四季度将其在 Medtronic 的头寸提高了 6.4%。捷克国家银行目前拥有 278,065 股医疗技术公司的股票，价值 22,212,000 美元，在上个季度又购买了 16,786 股。当前 82.06% 的股票由机构投资者持有。</p>
</div><h2>Medtronic Price Performance</h2>
<div class="lb-trans"><h2>Medtronic 价格表现</h2>
</div><p>Shares of NYSE MDT opened at $93.75 on Tuesday. Medtronic plc has a fifty-two week low of $75.96 and a fifty-two week high of $96.25. The company has a market cap of $120.24 billion, a PE ratio of 28.50, a P/E/G ratio of 2.22 and a beta of 0.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.39 and a current ratio of 1.90. The business has a 50-day simple moving average of $88.62 and a two-hundred day simple moving average of $87.84.</p>
<div class="lb-trans"><p>NYSE MDT 的股票周二开盘价为 93.75 美元。Medtronic plc 的 52 周低点为 75.96 美元，52 周高点为 96.25 美元。该公司的市值为 1202.4 亿美元，市盈率为 28.50，市盈增长比率为 2.22，贝塔值为 0.80。该公司的债务与股本比率为 0.48，速动比率为 1.39，流动比率为 1.90。该业务的 50 天简单移动平均线为 88.62 美元，200 天简单移动平均线为 87.84 美元。</p>
</div><ul>
<li>Medtronic’s Expansion Gains Momentum—Time for a Market Shift?</li>
</ul>
<div class="lb-trans"><ul>
<li>Medtronic 的扩张势头增强——市场转变的时机到了吗？</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last released its earnings results on Tuesday, February 18th. The medical technology company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.03. The company had revenue of $8.29 billion for the quarter, compared to the consensus estimate of $8.33 billion. Medtronic had a net margin of 12.83% and a return on equity of 14.07%. As a group, equities analysts expect that Medtronic plc will post 5.46 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Medtronic (NYSE:MDT - 获取免费报告) 最近于 2 月 18 日星期二发布了其财报。该医疗技术公司报告本季度每股收益为 1.39 美元，超出市场共识预期的 1.36 美元，超出幅度为 0.03 美元。该公司本季度的收入为 82.9 亿美元，而市场共识预期为 83.3 亿美元。Medtronic 的净利润率为 12.83%，股本回报率为 14.07%。整体来看，股票分析师预计 Medtronic plc 本财年的每股收益将达到 5.46。</p>
</div><h2>Medtronic Dividend Announcement</h2>
<div class="lb-trans"><h2>Medtronic 股息公告</h2>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be given a dividend of $0.70 per share. The ex-dividend date is Friday, March 28th. This represents a $2.80 dividend on an annualized basis and a yield of 2.99%. Medtronic's dividend payout ratio is currently 85.11%.</p>
<div class="lb-trans"><p>该公司最近宣布了季度股息，将于 4 月 11 日星期五支付。3 月 28 日星期五的股东将获得每股 0.70 美元的股息。除息日期为 3 月 28 日星期五。这代表着年化股息为 2.80 美元，收益率为 2.99%。Medtronic 的股息支付比率目前为 85.11%。</p>
</div><h2>Insider Buying and Selling at Medtronic</h2>
<div class="lb-trans"><h2>Medtronic 的内部买卖</h2>
</div><ul>
<li>Intuitive Surgical Leads the Pack in Robotic Surgery Innovation</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 在机器人手术创新中领先</li>
</ul>
</div><p>In related news, EVP Brett A. Wall sold 12,437 shares of Medtronic stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $90.00, for a total transaction of $1,119,330.00. Following the completion of the sale, the executive vice president now owns 40,979 shares of the company's stock, valued at $3,688,110. The trade was a 23.28 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.20% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁 Brett A. Wall 于 1 月 24 日星期五出售了 12,437 股 Medtronic 股票。该股票以平均价格 90.00 美元出售，总交易额为 1,119,330.00 美元。出售完成后，该执行副总裁现在拥有 40,979 股公司股票，价值 3,688,110 美元。此次交易使其持股减少了 23.28%。该交易已在向 SEC 提交的文件中披露，文件可通过此超链接获取。公司内部人士持有公司股票的 0.20%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师的升级和降级</h2>
</div><p>A number of equities analysts have recently issued reports on the company. Wells Fargo &amp; Company dropped their price target on Medtronic from $106.00 to $98.00 and set an &#34;overweight&#34; rating on the stock in a research report on Wednesday, November 20th. Citigroup raised shares of Medtronic from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their target price for the company from $92.00 to $107.00 in a research report on Tuesday, March 4th. Royal Bank of Canada reaffirmed an &#34;outperform&#34; rating and issued a $105.00 price target on shares of Medtronic in a research report on Wednesday, February 19th. Truist Financial cut their price objective on shares of Medtronic from $93.00 to $89.00 and set a &#34;hold&#34; rating on the stock in a report on Wednesday, December 18th. Finally, Robert W. Baird upped their target price on Medtronic from $90.00 to $91.00 and gave the stock a &#34;neutral&#34; rating in a report on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, eight have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Medtronic has a consensus rating of &#34;Hold&#34; and a consensus target price of $96.07.</p>
<div class="lb-trans"><p>一些股票分析师最近对该公司发布了报告。富国银行将 Medtronic 的目标价从 106.00 美元下调至 98.00 美元，并在 11 月 20 日的研究报告中对该股票给予了 “增持” 评级。花旗集团将 Medtronic 的评级从 “中性” 上调至 “买入”，并在 3 月 4 日的研究报告中将其目标价从 92.00 美元上调至 107.00 美元。加拿大皇家银行在 2 月 19 日的研究报告中重申了 “跑赢大盘” 评级，并对 Medtronic 的股票设定了 105.00 美元的目标价。Truist Financial 在 12 月 18 日的报告中将 Medtronic 的目标价从 93.00 美元下调至 89.00 美元，并对该股票给予了 “持有” 评级。最后，Robert W. Baird 在 2 月 19 日的报告中将 Medtronic 的目标价从 90.00 美元上调至 91.00 美元，并对该股票给予了 “中性” 评级。一位研究分析师对该股票给予了卖出评级，八位给予了持有评级，六位给予了买入评级，一位给予了强烈买入评级。根据 MarketBeat.com 的数据，Medtronic 的共识评级为 “持有”，共识目标价为 96.07 美元。</p>
</div><p><strong>View Our Latest Stock Report on Medtronic</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 Medtronic 股票报告</strong></p>
</div><h2>Medtronic Company Profile</h2>
<div class="lb-trans"><h2>Medtronic 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>Medtronic plc 开发、制造并销售基于设备的医疗疗法，面向全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>TSX Venture Exchange (Formerly Canadian Venture Exchange)</li>
<li>How to Protect Your Portfolio When Inflation Is Rising</li>
<li>What is a support level?</li>
<li>3 Tech Stocks Defying Sector Weakness and Thriving in 2025</li>
<li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li>
<li>Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过美敦力</li>
<li>多伦多证券交易所创业板（前身为加拿大创业交易所）</li>
<li>如何在通货膨胀上升时保护你的投资组合</li>
<li>什么是支撑位？</li>
<li>3 只在 2025 年逆势而上并蓬勃发展的科技股</li>
<li>股息贵族名单中的最佳：通过贵族指数积累财富</li>
<li>尽管面临挑战，诺和诺德计划击败 GLP-1 竞争对手</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对美敦力感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com 获取美敦力 plc（NYSE:MDT - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在美敦力吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑美敦力之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而美敦力并不在名单上。</p>
</div><p>While Medtronic currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然美敦力目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Riverbend Wealth Management LLC 收购了美敦力公司（NYSE:MDT）的新股份